“I am proud of the many ways our faculty, students and staff are champions of academic medicine in Tampa Bay. We have witnessed an extraordinary level of growth and expansion, admitting the most competitive and diverse incoming class in our college’s history, dramatically increasing our national research footprint, and forming one of the largest academic medical centers in Florida to improve health outcomes for our patients, their families and the communities we serve.”
- Charles J. Lockwood, MD, MHCM
Executive Vice President of USF Health & Dean of the Morsani College of Medicine
Stronger than Ever
Standout MCOM Class of 2025
Over the past several years, each of MCOM’s incoming classes have outperformed previous classes. The Class of 2025, heralded as the most diverse and academically competitive incoming first-year class in the school’s history, boasts a school record 3.83 average GPA and a 517 median MCAT score, placing them in the 94th percentile across the country. A record 20% of the students come from traditionally underrepresented in medicine (URM), a tremendous increase from 6% seven years ago.
In September 1971, the doors of Florida’s newest medical school opened to 24 students, launching an MD program at USF that has since grown to be one of the top producers of physicians in the state.Read More
MCOM’s Department of Graduate Medical Education (GME) trains a total of 778 trainees, with 565 residents and 213 fellows in 65 accredited residency programs at 22 clinical practice sites in Florida.Read More
Fourth-year medical students from the MCOM Class of 2021 successfully matched to residency programs in Florida and across the nation.Read More
USF Health MCOM’s Department of Radiology 3D-printed nasal swab helps worldwide COVID-19 testing shortage
To date, more than 70 million 3D-printed nasal swabs have been produced in 56 countries using the USF Health-patented design, including by several hospitals and academic medical centers, many state governments, and international agencies and health care facilities.Learn More
Raising the Bar
for Research Excellence
MCOM champions translating discoveries to best-practice clinical care by building translational research programs. We have made great strides in increasing the quality and diversity of research, helping drive the University of South Florida’s record growth in federally sponsored research, and recruiting preeminent NIH-funded scientists.
U.S. News & World Report ranked MCOM as the No. 48 Best Medical School in Research nationwide, among both public and private universities in the U.S.
Jerri Edwards, PhD, was awarded a five-year, $44.4 million NIH-funded grant to test whether computerized brain training reduces dementia risk as part of the largest primary prevention trial to date.Read More
Jeffrey Krischer, PhD, director of the USF Health Informatics Institute, has attracted $533 million in NIH-funded awards over the past ten years, largely on Type 1 diabetes and related autoimmune diseases, becoming a worldwide hub for epidemiological research.Read More
A 2019 Nature Medicine paper led by USF Health Informatics Institute researchers was recently recognized as one of 24 key advances in diabetes research since insulin was discovered 100 years ago.Read More
Ying Yang, PhD, an assistant professor of molecular pharmacology and physiology, led a Heart Institute preclinical study that identified the gene Foxo1 as a potential treatment target for hereditary lymphedema. The research was published in The Journal of Clinical Investigation.Read More
Ganesh Halade, PhD, an associate professor of cardiovascular sciences, leads a National Heart, Lung and Blood Institute-funded team at the USF Health Heart Institute. Dr. Halade and collaborators recently reported research in JCP-Heart and Circulation defining the heart-spleen connection in cardiac repair.Read More
Creating a Microbiomes Institute to improve human & environmental health
As the former President of world-renowned Pasteur Institute, USF Health Professor, Christian Brechot, MD, PhD, creates an interdisciplinary Institute for Microbiomes, becoming the first university-based institute to launch in Florida. USF recently became one of only 38 U.S. academic institutions granted membership to the Microbiome Centers Consortium over the last two years.View Blog
USF Health MCOM’s primary teaching hospital, Tampa General Hospital (TGH), ranks nationally in five adult medical specialties by U.S. News & World Report.
TGH is ranked the #1 Best Hospital in Tampa Bay for the sixth consecutive year. Five adult medical specialties ranked in the top 50 nationwide are led or co-led by USF Health faculty.Learn More
Five adult medical specialties ranked No. 1 in Florida by the latest U.S. News & World Report rankings list of the Best Hospital nationwide.
USF Health’s clinical enterprise earned a reporting score of 100 on the CMS Medicare Access and CHIP Reauthorization Act (MACRA) Merit based Incentive Payment System (MIPS).
USF Health in collaboration with TGH adopt a new intravascular technology, and successfully treated the first patient in the world with critical coronary artery disease.
USF Health and Tampa General Hospital brings an enhanced clinical enterprise to Tampa Bay
MCOM recently strengthened its longstanding relationship with primary teaching hospital and chief academic partner, Tampa General Hospital (TGH), aligning administrative and clinical practice areas into a joint organization called USF and Tampa General Physicians. This imposing physician enterprise, with over 40 clinical sites and more than 1,000 providers, forms one of the largest academic medical groups in Florida.Learn More
Led by Dr. Judette Louis, chair of the USF Health MCOM Department of Obstetrics and Gynecology, key TGH maternal health programs to reduce placental accreta and advance the safety of vaginal birth after cesarean, earned first-in-the-nation dual recognition from the Maternal Safety Foundation.Read More
The USF Health ALS Clinic was designated as one of only two sites in Florida for the CENTAUR clinical trial, which tested the safety and effectiveness of a new treatment shown to significantly benefit ALS patients. The New England Journal of Medicine published results of the highly anticipated study.Read More
USF Health Genetics and Metabolism and TGH delivered one of the world’s first investigational gene therapies for the rare inherited disease phenylketonuria (PKU) as part of a pivotal multisite clinical trial. USF Health is one of four sites – three in the U.S. and one in the United Kingdom – testing an adenovirus vector-mediated gene therapy for PKU.Read more
MCOM’s primary oncology hospital partner, Moffitt Cancer Center, is ranked #26 Best Cancer Hospital nationally in the latest U.S. News & World Report Best Hospitals rankings.
USF Health rapidly expanded Telehealth within a week with Microsoft Teams to keep patients connected to medical specialists during the COVID-19 pandemic -more than any multispecialty group in Tampa Bay.
MCOM researchers have launched several clinical trials, including a pediatric vaccine trial, as part of the world-wide effort to reduce the severity and even prevent COVID-19.
USF Health and Tampa General Hospital Heart and Vascular Institute
The USF Health and TGH Heart and Vascular Institute is designed to be a destination cardiovascular institute built on the best clinical and scientific expertise at both USF Health and TGH. The institute benefits from innovative opportunities provided by organizations outside of the academic medical center, including private practices and biomedical industry.Learn More